492 related articles for article (PubMed ID: 25369795)
21. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin.
Zellweger T; Chi K; Miyake H; Adomat H; Kiyama S; Skov K; Gleave ME
Clin Cancer Res; 2002 Oct; 8(10):3276-84. PubMed ID: 12374699
[TBL] [Abstract][Full Text] [Related]
22. Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models.
Gravina GL; Marampon F; Sherris D; Vittorini F; Di Cesare E; Tombolini V; Lenzi A; Jannini EA; Festuccia C
Prostate; 2014 Jun; 74(8):852-68. PubMed ID: 24715588
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
[TBL] [Abstract][Full Text] [Related]
24. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
25. The radiation response of androgen-refractory prostate cancer cell line C4-2 derived from androgen-sensitive cell line LNCaP.
Xie BX; Zhang H; Yu L; Wang J; Pang B; Wu RQ; Qian XL; Li SH; Shi QG; Wang LL; Zhou JG
Asian J Androl; 2010 May; 12(3):405-14. PubMed ID: 20118949
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of human DAB2IP gene expression in prostate cancer cells results in resistance to ionizing radiation.
Kong Z; Xie D; Boike T; Raghavan P; Burma S; Chen DJ; Habib AA; Chakraborty A; Hsieh JT; Saha D
Cancer Res; 2010 Apr; 70(7):2829-39. PubMed ID: 20332235
[TBL] [Abstract][Full Text] [Related]
27. Constitutive mRNA expression of DNA repair-related genes as a biomarker for clinical radio-resistance: A pilot study in prostate cancer patients receiving radiotherapy.
Hümmerich J; Werle-Schneider G; Popanda O; Celebi O; Chang-Claude J; Kropp S; Mayer C; Debus J; Bartsch H; Schmezer P
Int J Radiat Biol; 2006 Aug; 82(8):593-604. PubMed ID: 16966187
[TBL] [Abstract][Full Text] [Related]
28. Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.
Tachon G; Cortes U; Guichet PO; Rivet P; Balbous A; Masliantsev K; Berger A; Boissonnade O; Wager M; Karayan-Tapon L
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282933
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells
Oka D; Sekine Y; Tsuji Y; Nakayama H; Miyazawa Y; Arai S; Koike H; Suzuki K
Anticancer Res; 2024 Jan; 44(1):93-98. PubMed ID: 38159995
[TBL] [Abstract][Full Text] [Related]
30. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
31. Cediranib suppresses homology-directed DNA repair through down-regulation of BRCA1/2 and RAD51.
Kaplan AR; Gueble SE; Liu Y; Oeck S; Kim H; Yun Z; Glazer PM
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092693
[TBL] [Abstract][Full Text] [Related]
32. Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.
Bridges KA; Toniatti C; Buser CA; Liu H; Buchholz TA; Meyn RE
Oncotarget; 2014 Jul; 5(13):5076-86. PubMed ID: 24970803
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of cyclooxygenase-2 correlates with resistance to radiation in human prostate adenocarcinoma cells.
Anai S; Tanaka M; Shiverick KT; Kim W; Takada S; Boehlein S; Goodison S; Mizokami A; Rosser CJ
J Urol; 2007 May; 177(5):1913-7. PubMed ID: 17437847
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
35. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
Martin RW; Orelli BJ; Yamazoe M; Minn AJ; Takeda S; Bishop DK
Cancer Res; 2007 Oct; 67(20):9658-65. PubMed ID: 17942895
[TBL] [Abstract][Full Text] [Related]
36. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.
Aloy MT; Hadchity E; Bionda C; Diaz-Latoud C; Claude L; Rousson R; Arrigo AP; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):543-53. PubMed ID: 17980509
[TBL] [Abstract][Full Text] [Related]
37. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
38. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).
Chinnaiyan P; Huang S; Vallabhaneni G; Armstrong E; Varambally S; Tomlins SA; Chinnaiyan AM; Harari PM
Cancer Res; 2005 Apr; 65(8):3328-35. PubMed ID: 15833866
[TBL] [Abstract][Full Text] [Related]
40. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies.
Gachechiladze M; Škarda J; Soltermann A; Joerger M
Int J Cancer; 2017 Oct; 141(7):1286-1294. PubMed ID: 28477336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
